Vapers Digest 20th December
Wednesday’s News at a glance:
THE ENDGAME FOR SMOKING? | With Paddy Costall and Jessica Harding
Global Forum on Nicotine
Control & Crisis | Relentless Pursuit of New Forms of Harm
Brent Stafford, Regulator Watch
For many years, the primary goal of tobacco control policy was to achieve what public health called the “tobacco endgame,” a goal that tobacco control pursued relentlessly.
That is until nicotine vapes upended the “quit or die” narrative and swiftly became the number one tool for smoking cessation, an outcome derided by many within public health, leading to a new endgame: the end of nicotine.That is until nicotine vapes upended the “quit or die” narrative and swiftly became the number one tool for smoking cessation, an outcome derided by many within public health, leading to a new endgame: the end of nicotine.
Juul Labs said on Tuesday it was seeking U.S. authorization for its new menthol-flavored pods, which require user age verification, to be used with its e-cigarette device that is under review by regulators.
Juul’s e-cigarettes were briefly banned in the U.S. in June 2022 after the U.S. Food and Drug Administration (FDA) concluded the company had failed to show that the sale of its products would be appropriate for public health. Following an appeal, the health regulator put the ban on hold and agreed to an additional review of Juul’s marketing application.
On this Day…2022
A look back at how things have moved on or otherwise…
Global State of THR:
ecig an unprecedented revolution – CoEHAR
Although the numbers of harm reduction supporters are growing, there are still too many smokers attracted to cigarettes: with over 1.1 billion smokers worldwide and more than 8 million smoke-related deaths each year, the smoking emergency is still a long way off from being in check.
Critics of FDA’s Tobacco Program
Vindicated by Reagan-Udall Foundation Review – Karl Abramson
On Monday, the Reagan-Udall Foundation released a highly anticipated report evaluating the Food and Drug Administration’s Center for Tobacco Products (CTP). The report highlights a stunning lack of direction and transparency within CTP that hinders the agency’s ability to effectively protect public health.
Visit Nicotine Science & Policy for more News from around the World